Companies Cryptocurrencies
Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc
Exchange: NasdaqGM
IPO Date: 15/06/2018
CEO: Mr. Ted White
Biotechnology Healthcare 🔗
  • VRCA
    symbol
  • 13.36
    price
  • 367596384
    market cap
  • 0.5199995
    changes
If you bought

shares of Verrica Pharmaceuticals Inc (VRCA) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. The company is headquartered in West Chester, Pennsylvania and currently employs 16 full-time employees. The firm is focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its lead product candidate, VP-102, is a drug-device combination of topical solution of cantharidin. The firm also intends to develop second cantharidin-based product candidate, VP-103, for the treatment of plantar warts. The firm has completed one Phase II clinical trial of topical solution of cantharidin administered with the wooden stick part of a cotton-tipped swab. The company also conducting another Phase II clinical trial of topical solution of cantharidin administered through applicator, which collectively refer to as VP-102, for the treatment of molluscum.

Address: 10 N High St Ste 200 West Chester PENNSYLVANIA 19380

Stay updated.